Don't miss these informative online events happening throughout the month of May. Photo by Getty Images

This month, Houstonians have yet another good batch of online innovation events — from Zoom panels to virtual conferences — and you and your tech network need to know about them.

Here's a roundup of virtual events not to miss this month — like Houston Tech Rodeo, a virtual showcase from Rice University's data science students, and more.

Note: This post might be updated to add more events.

May 4 — Perfecting Your Pitch

Join The Ion for our series with DeckLaunch and Fresh Tech Solutionz as they discuss the importance and value of your pitch deck when reaching your target audience.

The event is on Tuesday, May 4, at 1 pm. It's free and can be accessed online. Click here to register.

May 5 — D2K Virtual Showcase - Spring 2021

Join Rice University online for the interactive D2K Showcase. Student teams from the D2K Capstone and other data science programs will showcase their data science work and compete for prizes.

The event is on Wednesday, May 5, at 5 pm. It's free and can be accessed online. Click here to register.

May 6 — Carbon to Value Initiative Kickoff

Kick off a new accelerator dedicated to carbontech. The Carbon to Value (C2V) Initiative is a multi-year collaboration between The Urban Future Lab, Greentown Labs, and the Fraunhofer USA TechBridge Program. Welcome the first cohort of startups to this exciting new program, which includes Houston-based Cemvita Factory.

The event is on Thursday, May 6, at 3 pm. It's free and can be accessed online. Click here to register.

May 12 — Enventure "Inspire" Seminar Series - With Dr. Reece Norris

The "Inspire" Seminar Series was developed by Enventure to help students learn about the reality of working in the biotech and biomedical fields. This particular event will star Mr. Reece Norris, JD, co-founder and COO of WeInfuse. Reece began his career in corporate law and eventually entered the provider-based infusion center market, where he went on to create a first-of-its-kind infusion delivery business model.

The event is on Wednesday, May 12, at 6 pm. It's free and can be accessed online. Click here to register.

MAy 13 — Changing the Colors of Investment

Maria Maso of the Business Angel Minority Association and Stephanie Tsuru of SheSpace are planning an inspiring conversation on diversity in investment.

The event is on Thursday, May 13, at 11:30 am. It's free and can be accessed online. Click here to register.

May 14 — Investor Speaker Series: Navigating Corporate Venture Capital

Greentown Labs is putting on a virtual event about Corporate Venture Capital. CVCs have played an important role in advancing climatetech in general, and supporting the Greentown ecosystem specifically. In this conversation, we will connect with CVCs within the Greentown network—and representing diverse industries—to discuss what they look for in startups, how they work with startups, how they like to participate in deals, and their perspective on key trends in climatetech investing. Panelists include:

The event is on Friday, May 14, at 11 am. It's free and can be accessed online. Click here to register.

May 17-23 — Houston Tech Rodeo

The Houston Tech Rodeo — a festival of events put on both online and in person — celebrates the convergence of popular culture and innovation in Houston and has transformed into an essential destination for founders and talented individuals to spur new connections and ideas while highlighting all that Houston has to offer.

The round-up of events takes place May 17 to 23. Check out all the events and register by clicking here.

May 18 — Accessibility in Tech presented by Microsoft

Attendees at this event presented by Capital Factory can look forward to a keynote chat from a serial entrepreneur or investor, insightful discussion sessions, a startup showcase pitch competition, multiple future of accessibility breakout sessions, and panels on accessibility in design and accessibility in hiring and human resource management.

The event is on Tuesday, May 18, at noon. It's free and can be accessed online. Click here to register.

May 20 — Future of Patient Experience

Healthcare centered around the patient's experience is becoming a bigger priority for systems around the world. Join experts from Houston, Texas Medical Center, the UK, and Denmark for a Biobridge event. Healthcare centered around the patient's experience is becoming a bigger priority for systems around the world.

The event is on Thursday, May 20, at 9 am. It's free and can be accessed online. Click here to register.

May 25 — Industrial XR Forum: Enterprise Projects & Tech Roundup

The Industrial XR Forum is hosting an industry-wide event focused specifically on industrial/energy and engineering large enterprise and rapidly scaling immersive tech program leaders to gain insights, use cases and technology needed for their large and often global VR/AR/XR, 3D, Digital Twin and Spatial Computing projects.


The event is on Tuesday, May 25, at 10 am. It's free and can be accessed online. Click here to register.

May 25 — HYP Referral Networking: Building Stronger Relationships

Join the Houston Young Professionals and General Assembly for a virtual networking event.

The event is on Tuesday, May 25, at 11:45 am. It's free and can be accessed online. Click here to register.

May 25 — HALO Presents: Ongoing Changes in Consumer Behavior as a Result of Covid-19

The COVID-19 pandemic caused a significant shift in consumer behavior as cities around the world saw shut downs and restrictions. Every aspect of life was affected. As the the country reopens and we enter our new normal what trends from the pandemic will stick around and what will change? Join the Texas HALO Fund and some of its portfolio companies operating in the consumer space to hear their experiences of the pandemic first hand.

The event is on Tuesday, May 25, at 5 pm. It's free and can be accessed online. Click here to register.

May 26 — Houston Startup Showcase Semifinals

Four semifinalists will come together on the virtual stage and compete for a chance to move on to the The Ion's Startup Showcase Finals. Watch the four startups pitch their company and see who the judges will select to move on to the Final and have the opportunity to compete for a prize package. The presenting companies are:

The event is on Wednesday, May 26, at 6 pm. It's free and can be accessed online. Click here to register.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.